pharmaphorum

pharmaphorum Podcast

Science EN ↓ 347 episodes

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Author

pharmaphorum

Category

Science

Podcast website

pharmaphorum.podbean.com

Latest episode

Jul 7, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

The problems of animal research for human medicine and the alternatives 04.01.2024

In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust, a charity aiming to improve the safety of medicines by facilitating a transition to human biology-based drug development and testing. 

The race to develop innovative products and supply chain solutions 30.12.2023

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it comes to launching a biopharmaceutical product in Eu...

The smart-design evolution of the laboratory space 29.12.2023

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.

Investing in the gleams of positivity and hope for life sciences innovation 28.12.2023

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

Looking to the future of UK medical device exports 27.12.2023

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders in...

Exploring the reasons behind increasing burdens on clinical research sites 26.12.2023

In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.

An investor’s perspective on bio and tech 21.12.2023

In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with LongeVC. His fund focused on therapeutics, diagnostics, and life sciences infrastructure plays.

Why digital therapeutics (DTx) are effective and safe, but not being prescribed 19.12.2023

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.

AI drug discovery: Where we are and where we’re going 14.12.2023

Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime fellow to both the Royal Society and the Academy of Medical Sciences in the UK.

Retaining the human element in healthcare services whilst embracing the potential of robotics 12.12.2023

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology and business. Trained as a human-centric designer, Anderson helps align business strategy, purpose, and culture and tries to save the planet on the side. But, with his Academy of Robotics hat firmly in place, he’s also a player in the recent shift to...

Bringing women’s health up to speed for 21st Century human healthcare 07.12.2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and what Mithra is doing on an international scale to ameliorate that.

Creating a future where the healthcare ecosystem works for everyone 05.12.2023

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Ari Tulla, CEO and co-founder of Elo Health, about his ‘big vision’ to transform food – changing it from a leading cause of disease to the medicine it can be.

Key themes from Frontiers Health 2023, with the pharmaphorum team 30.11.2023

In today’s podcast, Nicole and Eloise sit down with host Jonah Comstock to talk about some of what they saw and heard at the show, including how digital health and digital therapeutics are shifting the paradigm of care sites, some lessons and discussions from the DtX Global Policy Summit, the World Economic Forum’s push for health equity and corporate accountability, and more. 

Reducing the stigma attached to psychedelics 28.11.2023

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sarah Bateup, therapy lead at Clerkenwell Health, a British start-up working to revolutionise the clinical research landscape by providing a holistic one-stop hub for drug development, trial design, and treatment delivery for complex mental health and neurological conditions – including psychedelic medicines and...

How birth tissue donations are fuelling the cell therapy revolution 23.11.2023

On today’s podcast, host Jonah Comstock chats with Priya Baraniak, chief business officer and head of process development and manufacturing at OrganaBio and Lindsay Davis, chief scientific officer for NextCell Pharma, about how this tissue is currently collected and used and how this status quo may need to change.

Immunometabolism: Providing a new era of targeted medicine 21.11.2023

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.

Retaining the human element of AI within pharma and healthcare 16.11.2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.

Resilience, empathy, and gratitude. A personal battle with breast cancer. 14.11.2023

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer.

The ‘elegant science’ in achieving the promise of ADCs 07.11.2023

In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.

Understanding the importance of the whole person in clinical research 02.11.2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with KimberLee Heidmann, executive vice president of patient experience and customer success at Scout Clinical, part of Meeting Protocol Worldwide, a Dallas-based family of brands providing full-service meeting planning for the pharmaceutical and biotechnology industry, as well as clinical trial patient concierge travel...

Why medical weight loss is more complicated than GLP-1s 27.10.2023

This week the podcast welcomes Dr Rekha Kumar, medical affairs lead at digital medical weight loss clinic Found. Kumar discusses how her practice has had to carefully integrate these new drugs and navigate the complexities around prescribing them.

Creating behavioural change through incremental, small steps 24.10.2023

In this latest episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Sarah Watters, senior consultant at Wellth, a company devoted to improving the health of people with chronic conditions by embracing, not denying, humanity.

How AI can bolster each step of the clinical trial journey 19.10.2023

In today's podcast, brought to you by Syneos Health, host Jonah Comstock is joined by Baba Shetty, president of technology and data solutions at Syneos Health, to talk about about how he and his team are leveraging the power of data and artificial intelligence to address these many changing dynamics.

Focussing on finding value in health sciences marketing 17.10.2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.

How big pharma cares for its own 12.10.2023

On today’s podcast, host Jonah Comstock is joined by Jamie Eden, SVP of human resources at Boehringer Ingelheim, the world's largest private pharmaceutical company, for a conversation about what BI is doing to support the mental health of its workers.

Listen to the pharmaphorum Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.